Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alpha Plus Cream Original is a topical skin-brightening cream developed by Avalon Pharmaceuticals. It is formulated with two natural active ingredients: alpha-arbutin (1% w/w) and glabridin (0.5% w/w). Alpha-arbutin, derived from bearberry, and glabridin, extracted from licorice root, both act as potent inhibitors of tyrosinase, the rate-limiting enzyme in melanin synthesis. By blocking tyrosinase activity, the cream reduces melanin production, helping to fade dark spots, hyperpigmentation, and blemishes, and to unify skin tone. It is designed for use on the face, body, and sensitive areas such as the underarms and bikini line.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Alpha Plus Cream Original.